Delivery Order SPE2DB22D1106-SPE2DB25FFBR2
- Not listed
- The Defense Logistics Agency awarded a $1,837.56 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a completion deadline of July 30, 2025, and represents a child contract under AmerisourceBergen's larger federal contract portfolio. The award carries no set-aside designation, indicating it was competitively awarded. Performance will occur at the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units, with a ceiling value of $1,225.04. This firm fixed-price delivery order is scheduled for completion by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for supply of Nucynta (tapentadol) 100 mg tablets in quantities of 100 units. This is a firm fixed price delivery order with a ceiling value of $1,845.89 and ultimate completion date of September 5, 2025. The contract carries no set-aside designation and represents a competitive award. Performance of this delivery order is based at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Nucynta ER (tapentadol extended-release) 100mg tablets, valued at $6,005.43. This firm fixed-price delivery order, which represents a child contract under a larger vehicle, is scheduled for completion by August 5, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made through open...
- The Defense Logistics Agency awarded a $2,862.27 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Nucynta (tapentadol) 100 mg tablets in a 100-count package. This competitively awarded, non-set-aside contract will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. The delivery order represents a child contract action under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,848.19 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in a quantity of 100 units. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's larger indefinite delivery contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units, with a ceiling value of $1,225.04. This firm fixed-price delivery order, which must be completed by August 12, 2025, represents a competitive award with no set-aside designation and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen...
- On June 2, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $7,350.24 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100. This firm fixed-price delivery order, with an ultimate completion date of June 3, 2025, represents a continuation of the company's extensive pharmaceutical support to the Department of Defense medical procurement system. The award is non-competitive with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in a quantity of 100 units under a firm fixed-price contract with a ceiling value of $1,225.04. The award was issued on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive, non-set-aside procurement. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,253.88 to AmerisourceBergen Drug Corp for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This competitive delivery order, which was not set-aside for any socioeconomic category, was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, under firm fixed-price terms. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFBR2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with a ceiling value of $1,225.04 and an ultimate completion date of August 6, 2025. The award represents a non-competitive action under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, continues to fulfill DLA's pharmaceutical supply requirements under its comprehensive IDC vehicle. The delivery order for this pain management pharmaceutical exemplifies the company's role in supporting military and federal healthcare systems with both brand-name and generic medications across multiple therapeutic domains. As a child contract under the larger DLA pharmaceutical support agreement, this delivery order represents routine procurement activity within the established vendor relationship to supply specialized medications to federal customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/5/25 |